SAI Life Sciences Ltd
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · India · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
survey no. 133 Gachibowli Miyapur Rd, Ga...Phone Number
(908) 850-3460Website
www.sailife.comRevenue
$273.8 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
3
1
1
About SAI Life Sciences Ltd
SAI Life Sciences Ltd. formerly known as SAI Advantium Pharma Limited provides drug discovery, development, and manufacturing services for pharmaceutical and biotechnology. It offers synthetic & medicinal chemistry services, biology services, pre-formulation, NCE formulation, generic formulation development, and re-formulation & maintenance. The company was founded in 1999 and is headquartered in Gachibowli, Telangana, India.Explore more
SAI Life Sciences Ltd Org Chart
SK
Senior Vice President
PG
Senior VP, Manufacturing
AV
Senior Vice President
SC
Senior VP, Health & Operational Excellence
DM
Vice President
SH
Vice President
VM
Vice President
SH
Head Associate VP, Operational Excellence
LI
Associate VP, Project Management (Discovery)
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is SAI Life Sciences Ltd your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when SAI Life Sciences Ltd launches new products
Check if SAI Life Sciences Ltd has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
SAI Life Sciences Ltd, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at SAI Life Sciences Ltd
Funding: Get notified immidiatlly once SAI Life Sciences Ltd has new funding data
Earning: See what the market has to say on SAI Life Sciences Ltd recently announced quarterly report
Check out if SAI Life Sciences Ltd is spiking on competitors!
Click to see if SAI Life Sciences Ltd had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
SAI Life Sciences Ltd is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
SAI Life Sciences Ltd is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about SAI Life Sciences Ltd.
SAI Life Sciences Ltd Tech Stack
A closer look at the technologies used by SAI Life Sciences Ltd
See more technologies
Most Recent Scoops
Project
SAI Life Sciences Ltd is investing in biology-heavy discovery services including in vitro biology, human cell-based assays, and organoids in anticipation of increasing demand driven by the FDA's push toward New Approach Methodologies, which is expected to reshape discovery workflows over the next several years.
Spending/Investment, Bioengineering, Medical Research
Earnings
SAI Life Sciences Ltd has reiterated its aspiration to maintain revenue growth of 15% to 20% while sustaining EBITDA margins in the 28% to 30% range over a three-year period, with the second half of FY 2027 expected to be stronger than the first half as new capacities and investments progressively come on stream.
Earnings, Spending/Investment, Financial Planning, Forecasting, Finance, Financial Strategy
Earnings
SAI Life Sciences Ltd has reported that its top 10 customers contributed 54%, top 5 customers contributed 37%, and its single largest customer contributed 12% of total revenues in FY 2026, with top customer engagement spanning multiple services to reduce concentration risk at any individual service level.
Earnings, Customer Engagement, Customer Retention & Development, Finance, Risk
Earnings
SAI Life Sciences Ltd has reported that new technology revenue salience declined from 7% to 4% in FY 2026, reflecting the clinical-stage nature of new modality work, which generates campaign-based rather than continuous revenue and contributes to inherent revenue variability in the CDMO business.
Clinical Operations, Revenue Operations
Project
Research & Development, Pharmaceuticals
SAI Life Sciences Ltd News & Media
Sai Life Sciences Releases Sustainability Report 2024–25
Sai Life Sciences Releases Sustainability Report 2024–25Sai Life Sciences, Agility Life Sciences, and Centrix Pharma Solutions announce an ‘Integrated CMC Partnership’ to accelerate drug development for innovators
MANCHESTER, United Kingdom and HYDERABAD, India, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Sai Life Sciences (BSE: 544306 | NSE: SAILIFE), Agility Life Sciences, and Centrix Pharma Solutions today announced the launch of an Integrated CMC Partnership designed to provide innovator biopharma companies with end-to-end Chemistry, Manufacturing and Controls (CMC) services. The collaboration combines the extensive CMC expertise of Sai Life Sciences in API development, Agility Life Sciences in formulation deveSai Life Sciences CFO sees revenue growing 15-20% CAGR in 3-5 yrs - Informist Media
Sai Life Sciences Ltd. expects its earnings before interest, tax, depreciation, and amortisation margin to touch 28-30% in the next 2-3 years from the current 25%, led by capacity expansion and roSai Life Sciences completes Phase II of Production Block 11 at Bidar site, India, expands capacity to 700 KL
HYDERABAD, India, Aug. 28, 2025 (GLOBE NEWSWIRE) -- Sai Life Sciences Limited (BSE: 544306 | NSE: SAILIFE), an innovator-focused Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the completion of Phase II of its new Production Block (PB-11) at the company’s flagship API manufacturing facility in Bidar, India (Unit IV).
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding SAI Life Sciences Ltd
Sign Up For FreeTo access detailed company insights
SAI Life Sciences Ltd. formerly known as SAI Advantium Pharma Limited provides drug discovery, development, and manufacturing services for pharmaceutical and biotechnology. It offers synthetic & medicinal chemistry services, biology services, pre-formulation, NCE formulation, generic formulation development, and re-formulation & maintenance. The co... Read More
